BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 24444854)

  • 1. Which target is best for patients with Parkinson's disease? A meta-analysis of pallidal and subthalamic stimulation.
    Sako W; Miyazaki Y; Izumi Y; Kaji R
    J Neurol Neurosurg Psychiatry; 2014 Sep; 85(9):982-6. PubMed ID: 24444854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacies of globus pallidus stimulation and subthalamic nucleus stimulation for advanced Parkinson's disease: a meta-analysis of randomized controlled trials.
    Tan ZG; Zhou Q; Huang T; Jiang Y
    Clin Interv Aging; 2016; 11():777-86. PubMed ID: 27382262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients With Parkinson's Disease: Executive Summary.
    Rughani A; Schwalb JM; Sidiropoulos C; Pilitsis J; Ramirez-Zamora A; Sweet JA; Mittal S; Espay AJ; Martinez JG; Abosch A; Eskandar E; Gross R; Alterman R; Hamani C
    Neurosurgery; 2018 Jun; 82(6):753-756. PubMed ID: 29538685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STN versus GPi deep brain stimulation for dyskinesia improvement in advanced Parkinson's disease: A meta-analysis of randomized controlled trials.
    Zhang J; Li J; Chen F; Liu X; Jiang C; Hu X; Ma L; Xu Z
    Clin Neurol Neurosurg; 2021 Feb; 201():106450. PubMed ID: 33421741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial.
    Odekerken VJ; van Laar T; Staal MJ; Mosch A; Hoffmann CF; Nijssen PC; Beute GN; van Vugt JP; Lenders MW; Contarino MF; Mink MS; Bour LJ; van den Munckhof P; Schmand BA; de Haan RJ; Schuurman PR; de Bie RM
    Lancet Neurol; 2013 Jan; 12(1):37-44. PubMed ID: 23168021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognition and Depression Following Deep Brain Stimulation of the Subthalamic Nucleus and Globus Pallidus Pars Internus in Parkinson's Disease: A Meta-Analysis.
    Combs HL; Folley BS; Berry DT; Segerstrom SC; Han DY; Anderson-Mooney AJ; Walls BD; van Horne C
    Neuropsychol Rev; 2015 Dec; 25(4):439-54. PubMed ID: 26459361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease.
    Moro E; Lozano AM; Pollak P; Agid Y; Rehncrona S; Volkmann J; Kulisevsky J; Obeso JA; Albanese A; Hariz MI; Quinn NP; Speelman JD; Benabid AL; Fraix V; Mendes A; Welter ML; Houeto JL; Cornu P; Dormont D; Tornqvist AL; Ekberg R; Schnitzler A; Timmermann L; Wojtecki L; Gironell A; Rodriguez-Oroz MC; Guridi J; Bentivoglio AR; Contarino MF; Romito L; Scerrati M; Janssens M; Lang AE
    Mov Disord; 2010 Apr; 25(5):578-86. PubMed ID: 20213817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease.
    Chen T; Mirzadeh Z; Chapple KM; Lambert M; Shill HA; Moguel-Cobos G; Tröster AI; Dhall R; Ponce FA
    J Neurosurg; 2018 Mar; 130(1):109-120. PubMed ID: 29547091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial nonmotor effects of subthalamic and pallidal neurostimulation in Parkinson's disease.
    Dafsari HS; Dos Santos Ghilardi MG; Visser-Vandewalle V; Rizos A; Ashkan K; Silverdale M; Evans J; Martinez RCR; Cury RG; Jost ST; Barbe MT; Fink GR; Antonini A; Ray-Chaudhuri K; Martinez-Martin P; Fonoff ET; Timmermann L;
    Brain Stimul; 2020; 13(6):1697-1705. PubMed ID: 33038595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep brain stimulation for Parkinson's disease: meta-analysis of results of randomized trials at varying lengths of follow-up.
    Mansouri A; Taslimi S; Badhiwala JH; Witiw CD; Nassiri F; Odekerken VJJ; De Bie RMA; Kalia SK; Hodaie M; Munhoz RP; Fasano A; Lozano AM
    J Neurosurg; 2018 Apr; 128(4):1199-1213. PubMed ID: 28665252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight change after globus pallidus internus or subthalamic nucleus deep brain stimulation in Parkinson's disease and dystonia.
    Mills KA; Scherzer R; Starr PA; Ostrem JL
    Stereotact Funct Neurosurg; 2012; 90(6):386-93. PubMed ID: 22922491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of deep brain stimulation target on motor subtypes in Parkinson's disease.
    Katz M; Luciano MS; Carlson K; Luo P; Marks WJ; Larson PS; Starr PA; Follett KA; Weaver FM; Stern MB; Reda DJ; Ostrem JL;
    Ann Neurol; 2015 Apr; 77(4):710-9. PubMed ID: 25627340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication dose reductions after pallidal versus subthalamic stimulation in patients with Parkinson's disease.
    Evidente VG; Premkumar AP; Adler CH; Caviness JN; Driver-Dunckley E; Lyons MK
    Acta Neurol Scand; 2011 Sep; 124(3):211-4. PubMed ID: 20969559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do patient's get angrier following STN, GPi, and thalamic deep brain stimulation.
    Burdick AP; Foote KD; Wu S; Bowers D; Zeilman P; Jacobson CE; Ward HE; Okun MS
    Neuroimage; 2011 Jan; 54 Suppl 1():S227-32. PubMed ID: 20932923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
    Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
    Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of subthalamic nucleus or globus pallidus interna stimulation on oculomotor function in patients with Parkinson's disease.
    Fridley J; Adams G; Sun P; York M; Atassi F; Lai E; Simpson R; Viswanathan A; Yoshor D
    Stereotact Funct Neurosurg; 2013; 91(2):113-21. PubMed ID: 23343617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
    Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
    Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Effects of Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation on Motor Subtypes in Parkinson's Disease.
    Fan S; Liu D; Shi L; Meng F; Fang H; Liu H; Zhang H; Yang A; Zhang J
    World Neurosurg; 2022 Aug; 164():e245-e255. PubMed ID: 35489598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial.
    Okun MS; Fernandez HH; Wu SS; Kirsch-Darrow L; Bowers D; Bova F; Suelter M; Jacobson CE; Wang X; Gordon CW; Zeilman P; Romrell J; Martin P; Ward H; Rodriguez RL; Foote KD
    Ann Neurol; 2009 May; 65(5):586-95. PubMed ID: 19288469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.